Finance

Beta
Lists
TFX:NYSE
Teleflex Inc
$129.58
+1.38%
(+1.77) 1D
Jun 26, 3:14:06 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TFX...
Open
$126.76
High
$131.64
Low
$126.76
Mkt. cap
5.74B
Avg. vol.
589.32K
Volume
207.30K
Dividend
1.05%
Quarterly dividend
$0.34
Ex-dividend date
May 22, 2026
52-wk high
$139.67
52-wk low
$100.18
EPS
-$22.82
Beta
0.82
Shares outstanding
44.27M
No. of employees
16K
Open
$126.76
High
$131.64
Low
$126.76
Mkt. cap
5.74B
Avg. vol.
589.32K
Volume
207.30K
Dividend
1.05%
Quarterly dividend
$0.34
Ex-dividend date
May 22, 2026
52-wk high
$139.67
52-wk low
$100.18
EPS
-$22.82
Beta
0.82
Shares outstanding
44.27M
No. of employees
16K
News stories
From sources across the web
Profile
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer is Jason Weidman; Weidman is also the company's president. Wikipedia
About Teleflex Inc
CEOLiam Kelly
Employees15.5K
FoundedJan 1, 1943
HeadquartersWayne, Pennsylvania, United States
SectorMedical device
Analyst ratings
Based on 8 analysts giving stock ratings to TFX in the past 3 months
Buy
Buy
4
Hold
4
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for TFX in the last 3 months.
Highest
Current $129.58
$160.00 (+23.48%)
Average
$146.00 (+12.67%)
Lowest
$135.00 (+4.18%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Bednar
Piper Sandler
Buy
Initiated
$160.00
+23.5%
06/08/2026
Richard Newitter
Truist Financial
Hold
Reiterated
$143.00
+10.4%
05/11/2026
Ravi Misra
Truist Financial
Hold
Reiterated
$143.00
+10.4%
05/11/2026
Jayson Bedford
Raymond James
Buy
Maintained
$150.00
+15.8%
05/08/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
$140.00
+8%
05/08/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$138.00
+6.5%
05/08/2026
Shagun Singh Chadha
RBC Capital
Buy
Upgraded
$155.00
+19.6%
05/08/2026
Michael Matson
Needham
Buy
Maintained
$147.00
+13.4%
05/07/2026
Unknown Analyst
Mizuho Securities
Hold
Maintained
$135.00
+4.2%
04/13/2026
Travis Steed
Bank of America Securities
Hold
Upgraded
$135.00
+4.2%
04/13/2026
Patrick Wood
Morgan Stanley
Buy
Reiterated
$155.00
+19.6%
03/16/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$1.39 / $1.22
+13.62%beat
Revenue / Est. (USD)
548.26M / 537.59M
+1.99%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
780.89M
913.02M
-401.87M
548.26M
Cost of goods sold
349.80M
460.78M
-251.05M
239.54M
Cost of revenue
349.80M
460.78M
-251.05M
239.54M
Research and development expenses
38.52M
57.23M
12.63M
44.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
203.88M
281.76M
-457.00K
218.51M
Operating expense
242.40M
338.99M
12.17M
262.90M
Total operating expenses
592.21M
799.77M
-238.88M
502.43M
Operating income
188.68M
113.25M
-162.98M
45.83M
Other non operating income
-
-
-
-
EBT including unusual items
135.25M
-438.58M
218.94M
-3.83M
EBT excluding unusual items
168.62M
83.57M
-190.43M
21.82M
Income tax expense
12.66M
-29.70M
-30.78M
1.01M
Effective tax rate
9.36%
6.77%
-14.06%
-26.42%
Other operating expenses
-
-
-
-
Net income
122.58M
-408.89M
-714.33M
-8.15M
Net profit margin
15.70%
-44.78%
177.75%
-1.49%
Earnings per share
3.73
3.67
1.93
1.39
Interest and investment income
1.64M
2.16M
680.00K
1.71M
Interest expense
-21.71M
-31.84M
-28.13M
-25.72M
Net interest expenses
-20.06M
-29.68M
-27.45M
-24.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
254.40M
191.18M
-118.55M
99.57M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of TFX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more